Spots Global Cancer Trial Database for Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas
Official Title: Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas - Substudy of the ENSAT (European Network for the Study of Adrenal Tumor) Registry
Study ID: NCT04917757
Conditions
Interventions
Study Description
Brief Summary: The primary aim of the study is to assess mortality and cardiovascular events potentially linked to cortisol excess in patients with adrenal incidentalomas stratified by cortisol values following the 1-mg overnight dexamethasone test.
Detailed Description: The NAPACA Outcome Study is part of the ENSAT Registry (https://registry.ensat.org/)
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University Hospital Würzburg, Würzburg, , Germany
University Turin, Turin, , Italy
Contact Details
Name: Martin Fassnacht, MD
Affiliation: Wuerzburg University Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
